Is Same-Day Discharge After Angioplasty Safe?

Overnight observation after coronary angioplasty has been the standard of care in the United States. The foundations for this practice go back to the early days of balloon angioplasty, when acute occlusion and access-site complications were frequent.

¿Es seguro dar el alta el mismo día luego de una angioplastia?

There are several registries and randomized studies showing the clear safety of same-day discharge after coronary angioplasty. This practice has multiple benefits, such as higher patient satisfaction, a reduction in hospital stay, and a reduction in procedural costs.

 

Despite the evidence, this strategy has been widely resisted in everyday practice, particularly in the United States, where the rate of same-day discharge between 2004 and 2008 was barely 1.25%. This can be credited to medical custom, concerns about safety, lack of training on transradial access or percutaneous closure devices.

 

Many of these reasons (that prevent the implementation of same-day discharge) have recently improved. In consequence, this study assesses whether the trend has been reversed or if, on the contrary, we must continue to manage patients the same we did in the early days of balloon angioplasty.


Read also: Routine FFR in Patients with Acute Coronary Syndrome?”


The study assessed all patients registered in a database from Florida and New York who underwent coronary angioplasty sometime between 2009 and 2013.

 

The primary endpoints were unplanned readmissions within 7 and 30 days.

 

There was a modest increase in favor of same-day discharge over time, from 2.5% in 2009 to 7.4% in 2013 (p < 0.001). Same-day discharge was more frequently granted to male and younger patients with fewer comorbidities.


Read also: Minimum Appropriate Follow-Up Reduces Mortality After Endoprosthesis Implantation”.


There were considerable differences among different hospital types. Larger hospitals, university hospitals, and high angioplasty volume hospitals used same-day discharge much more frequently compared with smaller hospitals.

 

Same-day and next-day discharge patients had similar rates of unplanned readmission, mortality, and acute myocardial infarction.

 

Conclusion

During 2009 to 2013, there has been a modest increase in the use of same-day discharge for patients who have undergone coronary angioplasty. There were no differences as regards adverse events such as unplanned readmission, infarction, or death among same-day and next-day discharge patients.

 

Editorial

The successful implementation of a program for same-day discharge after coronary angioplasty requires that we know the exact kind of patient and procedure that would benefit the most from this practice.

 

Frailty, comorbidities, alarm guidelines, social support, and distance between home and the hospital may be parameters that help the process of choosing adequate patients.

 

In a similar systematic revision, there were no differences in risk between both patient groups. However, this study presents the exact opposite results.

 

Original title: Trends and Outcomes After Same-Day Discharge After Percutaneous Coronary Interventions.

Reference: Shikhar Agarwal et al. Circ Cardiovasc Qual Outcomes. 2017;10:e003936.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...